A combination of polymorphisms in HSD11B1 associates with in vivo 11β-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome
Authors:
- Alessandra GambineriAGAlessandra Gambineri
- Federica TomassoniFTFederica Tomassoni
- Alessandra MunariniAMAlessandra Munarini
- Roland H StimsonRSRoland H Stimson
- Roberto MioniRMRoberto Mioni
- Uberto PagottoUPUberto Pagotto
- Karen E ChapmanKCKaren E Chapman
- Ruth AndrewRARuth Andrew
- Vilma MantovaniVMVilma Mantovani
- Renato PasqualiRPRenato Pasquali
- Brian R WalkerBWBrian R Walker
- 1 August 2011
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 165 (2) , 283-292
Abstract
Objective: Regeneration of cortisol by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) within liver and adipose tissue may be of pathophysiological importance in obesity and the metabolic syndrome. single nucleotide polymorphisms (SNPs) in HSD11B1, the gene encoding 11β-HSD1, have been associated with type 2 diabetes and hypertension in population-based cohort studies, and with hyperandrogenism in patients with the polycystic ovary syndrome (PCOS). However, the functional consequences of these SNPs for in vivo 11β-HSD1 expression and activity are unknown.Methods: We explored associations of well-characterised hormonal and metabolic phenotypes with two common SNPs (rs846910 and rs12086634) in HSD11B1 in 600 women (300 with PCOS) and investigated 11β-HSD1 expression and activity in a nested study of 40 women from this cohort.Results: HSD11B1 genotypes (as single SNPs and as the combination of the two minor allele SNPs) were not associated with PCOS. Women who were heterozygous for rs846910 A and homozygous for rs12086634 T (GA, TT genotype) had a higher risk of metabolic syndrome, regardless of the diagnosis of PCOS (odds ratio in the whole cohort=2.77 (95% confidence interval (CI) 1.16–6.67), P=0.023). In the nested cohort, women with the GA, TT genotype had higher HSD11B1 mRNA levels in adipose tissue, and higher rates of appearance of cortisol and d3-cortisol (16.1±0.7 nmol/min versus 12.1±1.1, P=0.044) during 9,11,12,12-2H4-cortisol (d4-cortisol) steady-state infusion.Conclusions: We conclude that, in a population of Southern European Caucasian women with and without PCOS, alleles of HSD11B1 containing the two SNPs rs846910 A and rs12086634 T confer increased 11β-HSD1 expression and activity, which associates with the metabolic syndrome.Keywords
This publication has 38 references indexed in Scilit:
- 11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in Type 2 diabetes mellitus and obesityExpert Opinion on Investigational Drugs, 2008
- Metabolic syndrome without obesity: Hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic miceProceedings of the National Academy of Sciences, 2004
- Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic miceDiabetologia, 2002
- A Transgenic Model of Visceral Obesity and the Metabolic SyndromeScience, 2001
- Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11β-Hydroxysteroid Dehydrogenase Type 1 Null MiceJournal of Biological Chemistry, 2001
- Minireview: 11 -Hydroxysteroid Dehydrogenase Type 1-- A Tissue-Specific Amplifier of Glucocorticoid ActionEndocrinology, 2001
- Tissue-Specific Dysregulation of Cortisol Metabolism in Human ObesityThe Journal of Clinical Endocrinology & Metabolism, 2001
- Cortisol Metabolism in Human Obesity: Impaired Cortisone->Cortisol Conversion in Subjects with Central AdiposityThe Journal of Clinical Endocrinology & Metabolism, 1999
- 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stressProceedings of the National Academy of Sciences, 1997
- Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activationThe Journal of Clinical Endocrinology & Metabolism, 1995